Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials. [electronic resource]
Producer: 20090708Description: 1329-38 p. digitalISSN:- 1535-1386
- Aged
- Bone Density -- drug effects
- Bone Density Conservation Agents -- therapeutic use
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Fractures, Spontaneous -- drug therapy
- Humans
- Incidence
- Middle Aged
- Osteoporosis, Postmenopausal -- complications
- Prospective Studies
- Raloxifene Hydrochloride -- therapeutic use
- Reference Values
- Risk Assessment
- Severity of Illness Index
- Spinal Fractures -- drug therapy
- Teriparatide -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.